Italia markets closed

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqCM - NasdaqCM Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,6900+0,0400 (+2,42%)
Alla chiusura: 04:00PM EDT
1,7000 +0,01 (+0,59%)
Dopo ore: 06:35PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente1,6500
Aperto1,7000
Denaro1,6200 x 100
Domanda1,7400 x 100
Min-Max giorno1,6509 - 1,7100
Intervallo di 52 settimane1,3000 - 13,2000
Volume26.051
Media Volume859.384
Capitalizzazione2,473M
Beta (mensile su 5 anni)0,59
Rapporto PE (ttm)N/D
EPS (ttm)-22,0200
Prossima data utili07 ago 2024 - 12 ago 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A11,00
  • GlobeNewswire

    Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

    - Key Catalysts ahead with Multiple Value Generating Readouts-- Expects to Release Phase 1/2 Data with Oral Fadraciclib -- Signals of Single-agent Efficacy with Oral Plogosertib -- Management to Host Conference Call at 4:30 pm EDT Today- BERKELEY HEIGHTS, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical leader in cell cycle checkpoint control developing innovative medicines based on cancer cell

  • GlobeNewswire

    Cyclacel Pharmaceuticals to Release Second Quarter 2023 Financial Results

    BERKELEY HEIGHTS, N.J., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce second quarter 2023 financial results on Wednesday August 9, 2023. The Company will host a conference call and live webcast at 4:30 p.m. Eastern Daylight Time on the same day. Conference call information: Call: (800) 225-9448 / international call: